These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29961995)

  • 1. In search of cerebrospinal fluid biomarkers of fatigue in multiple sclerosis: A proteomics study.
    Valko PO; Roschitzki B; Faigle W; Grossmann J; Panse C; Biro P; Dambach M; Spahn DR; Weller M; Martin R; Baumann CR
    J Sleep Res; 2019 Jun; 28(3):e12721. PubMed ID: 29961995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
    Collins MA; An J; Hood BL; Conrads TP; Bowser RP
    J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseases.
    Menon KN; Steer DL; Short M; Petratos S; Smith I; Bernard CC
    Mol Cell Proteomics; 2011 Jun; 10(6):M110.000042. PubMed ID: 21421798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis.
    Kroksveen AC; Jaffe JD; Aasebø E; Barsnes H; Bjørlykke Y; Franciotta D; Keshishian H; Myhr KM; Opsahl JA; van Pesch V; Teunissen CE; Torkildsen Ø; Ulvik RJ; Vethe H; Carr SA; Berven FS
    Proteomics; 2015 Oct; 15(19):3361-9. PubMed ID: 26152395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis.
    Opsahl JA; Vaudel M; Guldbrandsen A; Aasebø E; Van Pesch V; Franciotta D; Myhr KM; Barsnes H; Berle M; Torkildsen Ø; Kroksveen AC; Berven FS
    Proteomics; 2016 Apr; 16(7):1154-65. PubMed ID: 26841090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics-based technologies in the discovery of biomarkers for multiple sclerosis in the cerebrospinal fluid.
    Lourenço AS; Baldeiras I; Grãos M; Duarte CB
    Curr Mol Med; 2011 Jun; 11(4):326-49. PubMed ID: 21506919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.
    Comabella M; Fernández M; Martin R; Rivera-Vallvé S; Borrás E; Chiva C; Julià E; Rovira A; Cantó E; Alvarez-Cermeño JC; Villar LM; Tintoré M; Montalban X
    Brain; 2010 Apr; 133(Pt 4):1082-93. PubMed ID: 20237129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid proteomics in multiple sclerosis.
    Kroksveen AC; Opsahl JA; Guldbrandsen A; Myhr KM; Oveland E; Torkildsen Ø; Berven FS
    Biochim Biophys Acta; 2015 Jul; 1854(7):746-56. PubMed ID: 25526888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers.
    Ottervald J; Franzén B; Nilsson K; Andersson LI; Khademi M; Eriksson B; Kjellström S; Marko-Varga G; Végvári A; Harris RA; Laurell T; Miliotis T; Matusevicius D; Salter H; Ferm M; Olsson T
    J Proteomics; 2010 Apr; 73(6):1117-32. PubMed ID: 20093204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential Features and Use Cases of the Cerebrospinal Fluid Proteome Resource (CSF-PR).
    Guldbrandsen A; Farag YM; Lereim RR; Berven FS; Barsnes H
    Methods Mol Biol; 2019; 2044():377-391. PubMed ID: 31432427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid.
    Bastos P; Ferreira R; Manadas B; Moreira PI; Vitorino R
    Crit Rev Clin Lab Sci; 2017 May; 54(3):185-204. PubMed ID: 28393582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proteomic analysis of cerebrospinal fluid of women newly diagnosed with multiple sclerosis.
    Jankovska E; Lipcseyova D; Svrdlikova M; Pavelcova M; Kubala Havrdova E; Holada K; Petrak J
    Int J Neurosci; 2022 Jul; 132(7):724-734. PubMed ID: 33059501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Novel Biomarkers for Diagnosing and Predicting the Progression of Multiple Sclerosis Using TMT-Based Quantitative Proteomics.
    Shi Y; Ding Y; Li G; Wang L; Osman RA; Sun J; Qian L; Zheng G; Zhang G
    Front Immunol; 2021; 12():700031. PubMed ID: 34489947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis.
    Mosleth EF; Vedeler CA; Liland KH; McLeod A; Bringeland GH; Kroondijk L; Berven FS; Lysenko A; Rawlings CJ; Eid KE; Opsahl JA; Gjertsen BT; Myhr KM; Gavasso S
    Sci Rep; 2021 Feb; 11(1):4087. PubMed ID: 33602999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of candidate biomarkers in converting and non-converting clinically isolated syndrome by proteomics analysis of cerebrospinal fluid.
    Timirci-Kahraman O; Karaaslan Z; Tuzun E; Kurtuncu M; Baykal AT; Gunduz T; Tuzuner MB; Akgun E; Gurel B; Eraksoy M; Kucukali CI
    Acta Neurol Belg; 2019 Mar; 119(1):101-111. PubMed ID: 29873030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased Neuro-Axonal Proteins in CSF at First Attack of Suspected Multiple Sclerosis.
    Stoop MP; Runia TF; Stingl C; van der Vuurst de Vries RM; Luider TM; Hintzen RQ
    Proteomics Clin Appl; 2017 Dec; 11(11-12):. PubMed ID: 28941200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-based profiling of cerebrospinal fluid within multiple sclerosis.
    Häggmark A; Byström S; Ayoglu B; Qundos U; Uhlén M; Khademi M; Olsson T; Schwenk JM; Nilsson P
    Proteomics; 2013 Aug; 13(15):2256-67. PubMed ID: 23696371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis.
    Stoop MP; Singh V; Dekker LJ; Titulaer MK; Stingl C; Burgers PC; Sillevis Smitt PA; Hintzen RQ; Luider TM
    PLoS One; 2010 Aug; 5(8):e12442. PubMed ID: 20805994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.
    Kroksveen AC; Opsahl JA; Aye TT; Ulvik RJ; Berven FS
    J Proteomics; 2011 Apr; 74(4):371-88. PubMed ID: 21111852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Mass Spectrometry-Based Assays for Relative Quantification of 30 Brain-Related Proteins and Their Clinical Applications.
    Begcevic I; Brinc D; Dukic L; Simundic AM; Zavoreo I; Basic Kes V; Martinez-Morillo E; Batruch I; Drabovich AP; Diamandis EP
    J Proteome Res; 2018 Jul; 17(7):2282-2292. PubMed ID: 29708756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.